The recent emergence of B.1.1.529, the Omicron variant 1 , 2 , has raised concerns of
escape from protection by vaccines and therapeutic antibodies. A key test for potential …

Omicron Neutralization and mRNA-1273 Boosters Neutralization of the omicron variant was
assessed in serum samples obtained from persons who had received an mRNA-1273 …

Background Vaccines to prevent coronavirus disease 2019 (Covid-19) are urgently needed.
The effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines on …

Ebola virus (EboV) causes rapidly fatal hemorrhagic fever in humans and there is currently
no effective treatment. We found that the infection of African green monkey kidney (Vero) cells …

Variant SARS-CoV-2 and the mRNA-1273 Vaccine How well do serum samples from persons
vaccinated with the mRNA-1273 vaccine neutralize the P.1 lineage, the B.1.1.7 lineage, …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal
antibodies (mAbs) can reduce the risk of hospitalization from coronavirus disease 2019 (…

Outbreaks of haemorrhagic fever caused by the Ebola virus are associated with high mortality
rates that are a distinguishing feature of this human pathogen. The highest lethality is …

Vaccines and therapies are urgently needed to address public health needs stemming from
emerging pathogens and biological threat agents such as the filoviruses Ebola virus (EBOV) …

INTRODUCTION Mass vaccination against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) offers the most efficient public health intervention to control the COVID-19 …

Containment of highly lethal Ebola virus outbreaks poses a serious public health challenge.
Although an experimental vaccine has successfully protected non-human primates against …